secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2026-10-02T21:27:47+00:00
Accession:  0001493152-26-045612
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

ChronoScale completes Ekso Bionics sale and signs AI infrastructure deals targeting $1B run-rate by Q3 2027
--------------------------------------------------------------------------------

- ChronoScale completed the sale of its Ekso Bionics business unit on September 30, 2026.
- COO Jason C. Jones was terminated effective September 30, 2026, under a Severance Agreement with Ekso.
- Severance includes a $243,750 lump sum, representing nine months of base salary, plus up to nine months of COBRA premiums.
- ChronoScale signed an agreement with a new AI infrastructure customer and extended an existing customer contract, targeting $1B annualized run-rate revenue by Q3 2027.
- ChronoScale terminated 5,852 shares of Series B Convertible Preferred Stock via a September 29, 2026 Withdrawal of Designation; no shares were outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226045612/0001493152-26-045612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000149315226045612/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-045612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer